TrialMalaria journal2016

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.

Mahamadou A Thera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.